Efficacy & Safety of KAPVAY™ Extended-Release in Children & Adolescents With Attention Deficit Hyperactivity Disorder
Clinical trial NCT01439126 · COMPLETED
Trial details
- NCT number
- NCT01439126
- Sponsor
- Concordia Pharmaceuticals Inc., Barbados
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2011-08-01
- Primary completion
- 2012-10-01
- Enrollment
- 135
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.